Not an SEC registrant

Avondale Capital, LLC

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Dec 31, 2025

10-K filed 2026-04-15

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 1

Companies Avondale Capital, LLC discloses as major customers, as a share of Avondale Capital, LLC revenue. 1 active, 0 lapsed.

Company	% of Avondale Capital, LLC revenue	Est. revenue	Period	Trend	Status	Source
VVOS Vivos Therapeutics, Inc.	Named	—	FY 2025-12-31	—	Active	10-K 2026-04-15
On December 5, 2025, we entered into a Note Purchase Agreement (the “Avondale Note Purchase Agreement”) with from Avondale Capital, LLC, a Utah limited liability company (“Avondale”), pursuant to which the Company issued and sold to Avondale a Promissory Note (the “Avondale Note”) in the original principal amount of $2,093,340 (the financing as described herein, the “Avondale Note Financing”). 10-K filed 2026-04-15 Period FY 2025-01-01 to 2025-12-31Accession 0001493152-26-016854

Alerts are coming

Get an email when Avondale Capital, LLC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.